Skip to content

Author

K. Asgaonkar

We have 4 of 49 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Harnessing Annona muricata phytochemicals for multi-target cancer therapy: An integrated network pharmacology and in-silico study.

Lung and breast cancers are among the major causes of cancer-related morbidity and mortality worldwide. Both these cancers share several dysregulated molecular processes, including common oncogenic signaling pathways and molecular targets. Therefore, the current study focuses on the dual anticancer potential of Annona...

S. Patil, Abhijit Das, K. Asgaonkar et al. · 0 citations
Aug 2026

Unveiling the Research Landscape of Triazole-based Aromatase Inhibitors in Breast Cancer: Bibliometric Insights

Breast cancer remains a leading cause of death among women, with one life lost approximately every 13 minutes. Postmenopausal women are particularly susceptible to Estrogen Receptor-positive (ER+) breast cancer. Aromatase inhibitors, including letrozole, exemestane, and anastrozole, suppress estrogen synthesis in p...

T. Chitre, K. Asgaonkar, Sonali S. Shelake et al. · 0 citations
Sep 2026

Integrated LC-MS and Computer-aided Drug Design Evaluation of Sida cordifolia Herbal Microemulsion Targeting Inflammatory Enzymes through Molecular Docking, MM-GBSA, DFT, and ADMET Profiling.

INTRODUCTION Sida cordifolia (SC) is traditionally used for treat inflammatory disorders; however, its molecular composition and the mechanistic basis of action remain poorly characterized. This study aimed to identify its bioactive constituents and elucidate their multi-target anti-inflammatory potential using an inte...

K. Asgaonkar, A. Avalaskar, K. Rajagopal et al. · 0 citations
Jul 2026

QSAR-Based Pharmacophore Optimization of 4-Aminoquinoline Derivatives: Computational Insights into Structure-Activity Relationship and Anticancer Potential

The results indicate that electronic and steric factors around the 4-aminoquinoline nucleus strongly influence anticancer activity, and the optimised pharmacophore provides a framework for designing new, more potent anticancer agents.

S. Patil, K. Asgaonkar, Darshani Gholap et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.